The Use of Levosimendan in the Treatment of Neurogenic Stress Cardiomyopathy in a Patient with Nontraumatic Subarachnoid Hemorrhage (Case Report)

We present a case of cardiogenic shock due to neurogenic stress cardiomyopathy (NSC) in a patient with nontraumatic subarachnoid hemorrhage caused by a ruptured aneurysm of the right pericallosal artery. Due to the catecholamine-resistant shock, levosimendan was administered under advanced hemodynam...

Full description

Saved in:

Bibliographic Details
Published in:	Obshchai͡a︡ reanimatologii͡a Vol. 17; no. 4; pp. 22 - 28
Main Authors:	Polupan, A. A., Tabasarankiy, T. F., Kheireddin, A. S., Savin, I. A., Zelenkova, O. M., Savchenk, Ya. V., Birg, T. M., Pashin, A. A., Sychev, A. A., Baranich, A. I., Belousova, O. B.
Format:	Journal Article
Language:	English
Published:	Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 27-08-2021
Subjects:	levosimendan neurogenic cardiomyopathy neurogenic pulmonary edema subarachnoid hemorrhage
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	We present a case of cardiogenic shock due to neurogenic stress cardiomyopathy (NSC) in a patient with nontraumatic subarachnoid hemorrhage caused by a ruptured aneurysm of the right pericallosal artery. Due to the catecholamine-resistant shock, levosimendan was administered under advanced hemodynamic control, including transpulmonary thermodilution and echocardiography. This resulted in an improved cardiac contractility and reduced demand for catecholamines. Full stabilization of hemodynamic parameters was achieved by day 5. In the discussion section we reviewed available published case reports of using levosimendan in stress cardiomyopathy treatment.
ISSN:	1813-9779 2411-7110
DOI:	10.15360/1813-9779-2021-4-22-28